https://orcid.org/0000-0002-2890-4728
References
- Caplan GA, Sulaiman NS, Mangin DA, et al., A meta-analysis of “hospital in the home.”. Med J Aust. 2012;197(9):512–519. cited 2016 Mar 30: https://www.mja.com.au/journal/2012/197/9/meta-analysis-hospital-home
- La prise en charge – FNEHAD. [cited 2016 Sept 19]. Available from: http://www.fnehad.fr/etre-pris-en-charge-en-had/
- Les métiers de l’HAD – FNEHAD. [cited 2016 Sept 19]. Available from: http://www.fnehad.fr/les-metiers-de-lhad/
- FNEHAD_RA_18x25cm_web.pdf. [cited 2016 Sept 19]. http://www.fnehad.fr/wp-content/uploads/2015/10/FNEHAD_RA_18x25cm_web.pdf
- PharmaDoc - DevelopingPharmacyPracticeEN.pdf. [updated 2016 30; cited 2016 Mar 30]. https://www.fip.org/files/fip/publications/DevelopingPharmacyPractice/DevelopingPharmacyPracticeEN.pdf
- Bedouch P, Allenet B, Grass A, et al. Drug-related problems in medical wards with a computerized physician order entry system. J Clin Pharm Ther. 2009;34(2):187–195.
- Pharmaceutical care network Europe. [updated 2016 30; cited 2016 Mar 30]. http://www.pcne.org/
- Allenet B, Bedouch P, Rose FX, et al. Validation of an instrument for the documentation of clinical pharmacists’ interventions. Pharm World Sci. 2006;28(4):181–188.
- Act IP v2. [cited 2016 Jun 21]. http://www.sfpc.eu/fr/groupes-travail/interventions-pharmaceutiques/16-pratiques-professionelles/173-act-ip-v2.html
- Bedouch P, Charpiat B, Conort O, et al. Assessment of clinical pharmacists’ interventions in French hospitals: results of a multicenter study. Ann Pharmacother. 2008;42(7):1095–1103.
- Blix HS, Viktil KK, Moger TA, et al. Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams. Pharm World Sci. 2006;28(3):152–158.
- Richardson TE, O’Reilly CL, Chen TF. Drug-related problems and the clinical role of pharmacists in inpatient mental health: an insight into practice in Australia. Int J Clin Pharm. 2014;36(5):1077–1086.
- Zaal RJ, Jansen MMPM, Duisenberg-van Essenberg M, et al. Identification of drug-related problems by a clinical pharmacist in addition to computerized alerts. Int J Clin Pharm. 2013;35(5):753–762.
- Lopez-Martin C, Garrido Siles M, Alcaide-Garcia J, et al. Role of clinical pharmacists to prevent drug interactions in cancer outpatients: a single-centre experience. Int J Clin Pharm. 2014;36(6):1251–1259.
- Triller DM, Clause SL, Briceland LL, et al. Resolution of drug-related problems in home care patients through a pharmacy referral service. Am J Health-Syst Pharm. 2003;60(9):905–910.
- Vink J, Morton D, Ferreri S. Pharmacist identification of medication-related problems in the home care setting. Consult Pharm. 2011;26(7):477–484.
- Reidt S, Morgan J, Larson T, et al. The role of a pharmacist on the home care team: a collaborative model between a college of pharmacy and a visiting nurse agency. Home Healthc Now. 2013;31(2):80–87.
- Krähenbühl JM, Kremer B, Guignard B, et al. Practical evaluation of the drug-related problem management process in Swiss community pharmacies. Pharm World Sci. 2008;30(6):777–786.
- Haavik S, Soeviknes S, Erdal H, et al. Prescriptions from general practitioners and in hospital physicians requiring pharmacists’ interventions. Pharmacoepidemiol Drug Saf. 2011;20(1):50–56.
- Leguelinel-Blache G, Arnaud F, Bouvet S, et al. Impact of admission medication reconciliation performed by clinical pharmacists on medication safety. Eur J Intern Med. 2014;25(9):808–814.
- Renaudin P, Esteve MA, Berbis J, et al. Les interventions pharmaceutiques dans un centre hospitalier universitaire : influence du mode de transmission sur leur acceptation par le prescripteur. Pharm Hosp Clin. 2016;51(1):2–8.
- Code de La Santé Publique - Article R5126-44-1. (Vol R5126-44-1).